Charles River Laboratories CRL Expected long-term rate of return on plan assets
Expected long-term rate of return on plan assets at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets.
The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's expected long-term rate of return on plan assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's expected long-term rate of return on plan assets?
- Charles River Laboratories (CRL) reported expected long-term rate of return on plan assets of $0.01 in Q4 2025.
- How has Charles River Laboratories's expected long-term rate of return on plan assets changed year-over-year?
- Charles River Laboratories's expected long-term rate of return on plan assets increased by 25.7% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Charles River Laboratories's expected long-term rate of return on plan assets?
- Over 2 years (2023 to 2025), Charles River Laboratories's expected long-term rate of return on plan assets has grown at a 6.2% compound annual growth rate (CAGR), from $0.04 to $0.04.
- What does expected long-term rate of return on plan assets mean?
- This is the long-term rate of return expected on the assets held in a defined benefit pension plan. It is used to calculate the expected return on plan assets, which offsets the total periodic benefit cost. This assumption is critical for managing the net expense of pension plans.